Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.90 -0.48% 185.00 3,961,698 16:35:27
Bid Price Offer Price High Price Low Price Open Price
184.40 184.60 186.40 183.10 183.30
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 1,377.77 14.25 3,670
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:27 UT 1,992,969 185.00 GBX

Convatec (CTEC) Latest News

More Convatec News
Convatec Investors    Convatec Takeover Rumours

Convatec (CTEC) Discussions and Chat

Convatec Forums and Chat

Date Time Title Posts
31/5/202013:12ConvaTec - placing at 225p376

Add a New Thread

Convatec (CTEC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-10-26 16:35:27185.001,992,9693,686,992.65UT
2020-10-26 16:29:59184.4011.84AT
2020-10-26 16:29:59184.4011.84AT
2020-10-26 16:29:59184.4011.84AT
2020-10-26 16:29:58184.4011.84AT
View all Convatec trades in real-time

Convatec (CTEC) Top Chat Posts

DateSubject
26/10/2020
08:20
Convatec Daily Update: Convatec Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker CTEC. The last closing price for Convatec was 185.90p.
Convatec Group Plc has a 4 week average price of 173.20p and a 12 week average price of 173.20p.
The 1 year high share price is 225.80p while the 1 year low share price is currently 142.40p.
There are currently 1,983,513,851 shares in issue and the average daily traded volume is 5,447,833 shares. The market capitalisation of Convatec Group Plc is £3,669,500,624.35.
31/5/2020
13:12
doubleorquits: Indeed, although I feel it may lose out to Kingfisher in the final furlong. The top four to replace the losers highlighted in The Observer are AVST,GVC,HSV and KGF at the moment although it is close between the latter and CTEC (I think all the others are safer bets). Review actually takes place at the close on Tuesday and changes become confirmed on Monday 22nd June. The following site is an excellent reference point for this: hTTp://stockchallenge.co.uk/ftse.php NB: All five might go in if ITV loses a bit more ground in the next three days.
31/5/2020
12:56
hootstox: Getting some coverage about FTSE100 changeover, CTEC could move up on Fridayhttps://www.theguardian.com/business/2020/may/30/ftse-reshuffle-relegation-easyjet-carnival-centrica-gaming
12/5/2020
14:25
brain smiley: 120 million share placing today.
29/7/2019
11:58
ny boy: Gap to fill on the breakout to 188/190p area ConvaTec Group Plc shows strong development within a rising trend channel in the medium long term. Rising trends indicate that the company experiences positive development and that buy interest among investors is increasing. The price has had a strong fall after the negative signal from rectangle formation at the break down through the support at 188. The objective at 152 is now met, but the formation signals further development in the same direction. The stock has broken up through the resistance at pence 147. This predicts a further rise. In case of negative reactions, there will now be support at pence 147. The stock is overall assessed as technically positive for the medium long term. Recommendation one to six months: Positive
28/7/2019
12:27
robow: CTEC gets a mention in todays Times Convatec could be a comfort in old age. 'there could be rewards ahead...BUY'
21/6/2019
07:48
uhound: Agree, the recent price action make me think this could do well! When it breaks 150 I suspect it will attract more interest!
22/1/2019
10:08
robow: One of Peel Hunt's stock picks for 2019 Convatec (CTEC) The depressed share price at medical products company Convatec has led to a rise in the dividend yield but the poor sentiment is unfounded. Analyst Amy Walker retained her ‘hold’ recommendation and target price of 170p on the stock. She said that ‘low visibility on earnings momentum has depressed the share price, leading to a rise in the dividend yield’ but even if the group misses her ‘conservative’ growth forecasts by 7% to 11% the company could still ‘yield at least 3% at the current share price, at the bottom of its target pay-out range’. Walker is not pessimistic about the outlook for the company, stating that the demand for the medical technology firm’s products were ‘unlikely to change materially from their mid-single digit market growth rates’. She added that the company can ‘support a stable to growing dividend’ but the most likely driver of volatility is the share price ‘which declined more than 30% on the most recent profit warning’.
30/10/2018
09:55
philanderer: Numis upgrades Convatec to ‘buy’ Numis has upgraded medical technology company Convatec (CTEC) after an ‘unwarranted’ 35% fall in the share price. Analyst Paul Cuddon upgraded his recommendation from ‘hold’ to ‘buy’ with a target price of 220p on the shares, which jumped 5.6% to 155p yesterday. ‘We do not think the loss of a chief executive and the decline in infusion devices warranted a 35% fall in Convatec’s share price, especially when the broader chronic care business is maintaining consistent 2% quarterly growth,’ he said. ‘We see full-year 2018 results, details on the self-help strategy and full-year 2019 outlook as key catalysts. The company trades on 10x enterprise value/earnings and offering sector leading free cashflow yield and so we upgrade to “buy”.’ HTTPS://citywire.co.uk/money/the-expert-view-just-eat-hsbc-and-iag/a1170201?re=59360&ea=290170&utm_source=BulkEmail_Money_Daily&utm_medium=BulkEmail_Money_Daily&utm_campaign=BulkEmail_Money_Daily#i=6
16/10/2018
07:25
robow: from Citywire Buying opportunity at Convatec, says Numis Medical technology company Convatec (CTEC) has delivered a poor third statement but the heavy share price fall could present a buying opportunity. The shares tumbled 34% to 148.2p yesterday after the company issued a profit warning and announced the departure of chief executive Paulk Moraviec. Analyst Paul Cuddon retained his ‘hold’ recommendation and target price of 220p on the shares. ‘Ultimately the statement reads poorly, but on our first take, the earnings per share downgrade is just 5% and should the shares fall materially we could see an interesting buying opportunity with the performance of the chronic care business showing continued steady growth,’ he said.
15/10/2018
19:46
cantrememberthis2: Despite the warning and its cautious stance on the stock, RBC said the share price reset has gone too far and highlighted the fact that Convatec is still a cash generative business with attractive qualities. "We would remind investors that Convatec is still a highly cash generative business, and at the current share price is generating a free cash flow yield of over 7%, with a dividend yield of 3%," it said. "With the performance wanting we would hope all options are now on the table to maximise shareholder value."
Convatec share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
CTEC
Convatec
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201027 05:16:13